These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 6114915)

  • 1. Somatostatin and insulin infusion in the management of diabetic ketoacidosis.
    Greco AV; Ghirlanda G; Altomonte L; Manna R; Rebuzzi AG; Bertoli A
    Horm Metab Res; 1981 Jun; 13(6):310-4. PubMed ID: 6114915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of diabetic ketoacidosis and hyperosmolality with low dose insulin infusion (author's transl)].
    Duclos F; François P; Dumon P; Altmann JJ
    Nouv Presse Med; 1978 Jun; 7(22):1919-24. PubMed ID: 97626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combined insulin and somatostatin infusion for the treatment of experimental diabetic ketoacidosis.
    Harano Y; Ohgaku S; Hidaka H; Takatsuki K; Shigeta Y
    Horm Metab Res; 1979 May; 11(5):338-42. PubMed ID: 113327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic ketoacidosis and hyperosmolar diabetic coma in childhood. Low-dose continuous intravenous infusion of insulin (author's transl)].
    Frank M; Hörnchen H; Joosten R
    Klin Padiatr; 1979 May; 191(3):271-9. PubMed ID: 110975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin on established induced ketosis.
    Fallucca F; Barbetti F; Maldonato A; Spallone V; Giangrande L; Gambardella S
    Horm Metab Res; 1982 Oct; 14(10):512-5. PubMed ID: 6129185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic ketoacidosis and coma. Insulin perfusion (author's transl)].
    Calvo Macías C; Santos García ; Martínez Carrasco MC; Ruza Tarrió F; Alvarado Ortega F
    An Esp Pediatr; 1980 Apr; 13(4):295-306. PubMed ID: 6772060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constant low-dose insulin infusion in severe diabetes mellitus.
    Hannan TJ; Stathers GM
    Med J Aust; 1976 Jan 3-10; 1(1-2):11-3. PubMed ID: 817112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of diabetic ketoacidosis in dogs by continuous low-dose intravenous infusion of insulin.
    Macintire DK
    J Am Vet Med Assoc; 1993 Apr; 202(8):1266-72. PubMed ID: 8496083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of diabetic ketoacidosis and hyperosmolar coma with low-dose insulin. Experience in a provincial hospital].
    Bello F; Gallo G; Reinbach R; Münzenmayer J; Latorre R; Garfe C; Bellolio T; Rodríguez C
    Rev Med Chil; 1982 Jan; 110(1):67-70. PubMed ID: 6818652
    [No Abstract]   [Full Text] [Related]  

  • 11. [Critical study of diabetic ketoacidosis in children. Initial description and course during the first 24 hours of treatment].
    Tubiana-Rufi N; Habita C; Czernichow P
    Arch Fr Pediatr; 1992 Mar; 49(3):175-80. PubMed ID: 1610273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose intravenous insulin infusion in patients with diabetic ketoacidosis: biochemical effects in children.
    Lightner ES; Kappy MS; Revsin B
    Pediatrics; 1977 Nov; 60(5):681-8. PubMed ID: 411105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low doses of insulin--comparison between hyperosmolar nonketotic coma and diabetic ketoacidosis (author's transl)].
    Pelosi RM; Reis LC
    Rev Bras Pesqui Med Biol; 1978 Oct; 11(4-5):249-58. PubMed ID: 103144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of diabetic keto-acidosis through continuous insulin infusion].
    Mirouze J; Mion C; Monnier L; Beraud JJ; Selam JL
    Nouv Presse Med; 1976 Nov; 5(37):2444-6. PubMed ID: 824621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiology and therapy of diabetic ketoacidosis and of non-ketoacidotic hyperosmolar diabetic coma].
    Waldhäusl W; Kleinberger G; Bratusch-Marrain P; Komjati M
    Wien Klin Wochenschr; 1984 Apr; 96(9):309-19. PubMed ID: 6433560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of diabetic ketoacidosis in children].
    Vanelli M; Bernasconi S; Rossi S; Rocca M; Turni A; Giovannelli G
    Arch Fr Pediatr; 1982 Apr; 39(4):203-7. PubMed ID: 6812531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of diabetic ketoacidosis by continuous infusion of low-dose insulin using the ordinary intravenous plastic bag and tubing.
    Mengistu M
    Ethiop Med J; 1991 Jan; 29(1):7-13. PubMed ID: 1900469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal insulin delivery in diabetic ketoacidosis (DKA) and hyperglycemic, hyperosmolar nonketotic coma (HHNC).
    Kitabchi AE; Matteri R; Murphy MB
    Diabetes Care; 1982; 5 Suppl 1():78-87. PubMed ID: 6821307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a 12-hour subcutaneous infusion of somatostatin-14 on blood glucose, insulin and glucagon levels in healthy subjects and insulin dependent diabetics.
    Villaume C; Beck B; Kolopp M; Toussain P; Debry G
    Biomed Pharmacother; 1986; 40(2):61-4. PubMed ID: 2875745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.